These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14279254)

  • 1. CHELATION BY CALCIUM TRISODIUM PENTETATE IN WORKERS EXPOSED TO LEAD.
    BRUGSCH HG; COLOMBO NJ; PAGNOTTO LD
    N Engl J Med; 1965 May; 272():993-6. PubMed ID: 14279254
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTION OF THE TRISODIUM MONOCALCIUM SALT OF DIETHYLENETRIAMINEPENTAACETIC ACID (CA DTPA NA3) IN HUMAN LEAD POISONING].
    MARTIN S; BOUDENE C; TRUHAUT R; ALBAHARY C
    Arch Mal Prof; 1964; 25():407-18. PubMed ID: 14175851
    [No Abstract]   [Full Text] [Related]  

  • 3. [DESFERRIOXAMINE (DF) AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID TRISODIUM CALCIUM SALT (CA DTPA NA3) IN SIDEROSIS. 2].
    ALBAHARY C
    Presse Med (1893); 1965 Jan; 73():73-6. PubMed ID: 14234334
    [No Abstract]   [Full Text] [Related]  

  • 4. TREATMENT OF LEAD ENCEPHALOPATHY. THE COMBINED USE OF EDETATE AND HEMODIALYSIS.
    SMITH HD; KING LR; MARGOLIN EG
    Am J Dis Child; 1965 Apr; 109():322-4. PubMed ID: 14261012
    [No Abstract]   [Full Text] [Related]  

  • 5. [CASE REPORT ON THE TREATMENT OF LEAD POISONING WITH THE CHELATING AGENT NA 2-EDTA IN SMALL DOSES].
    TEICHMANN W
    Z Gesamte Inn Med; 1963 Jul; 18():597-9. PubMed ID: 14047064
    [No Abstract]   [Full Text] [Related]  

  • 6. RESPONSE TO TREATMENT WITH CHELATING AGENTS OF ANAEMIA, CHRONIC ENCEPHALOPATHY, AND MYELOPATHY DUE TO LEAD POISONING.
    SIMPSON JA; SEATON DA; ADAMS JF
    J Neurol Neurosurg Psychiatry; 1964 Dec; 27(6):536-41. PubMed ID: 14249395
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON NEW VIEWS ON THE TREATMENT OF OCCUPATIONAL LEAD POISONING].
    SAVICEVIC M; PETROVIC L
    Vojnosanit Pregl; 1964 Mar; 21():173-7. PubMed ID: 14207475
    [No Abstract]   [Full Text] [Related]  

  • 8. [PREVENTION OF CHRONIC SATURNISM BY ORAL USE OF CALCIUM-SODIUM-EDTA].
    STANTSCHEW S
    Z Gesamte Hyg; 1964 Mar; 10():180-6. PubMed ID: 14291353
    [No Abstract]   [Full Text] [Related]  

  • 9. REVERSIBLE MYOCARDITIS DUE TO CHRONIC LEAD POISONING IN CHILDHOOD.
    FREEMAN R
    Arch Dis Child; 1965 Aug; 40(212):389-93. PubMed ID: 14329255
    [No Abstract]   [Full Text] [Related]  

  • 10. CHRONIC LEAD NEPHROPATHY: THE DIAGNOSTIC USE OF CALCIUM EDTA AND THE ASSOCIATION WITH GOUT.
    EMMERSON BT
    Australas Ann Med; 1963 Nov; 12():310-24. PubMed ID: 14078907
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON THE TOXICOLOGY OF DIETHYLENETRIAMINEPENTAACETIC ACIDS].
    CATSCH A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Jan; 246():316-29. PubMed ID: 14137057
    [No Abstract]   [Full Text] [Related]  

  • 12. THE PROPHYLACTIC USE OF DISODIUM-CALCIUM VERSENATE IN EXPERIMENTAL LEAD POISONING IN RABBITS. I. EFFECT ON THE BLOOD LEVELS OF REDUCED GLUTATHIONE.
    SROCZYNSKI J; JONDERKO G
    Arch Immunol Ther Exp (Warsz); 1964; 12():225-8. PubMed ID: 14166662
    [No Abstract]   [Full Text] [Related]  

  • 13. [CHELATION].
    RENOUX M; MIKOL C
    Presse Med (1893); 1964 Dec; 72():3117-9. PubMed ID: 14221352
    [No Abstract]   [Full Text] [Related]  

  • 14. Chelation in metal intoxication. XIII. Polyaminocarboxylic acids as chelators in lead poisoning.
    Tandon SK; Behari JR; Singh S
    Bull Environ Contam Toxicol; 1983 May; 30(5):552-8. PubMed ID: 6407551
    [No Abstract]   [Full Text] [Related]  

  • 15. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EFFECT OF THE DISODIUM SALT OF ETHYLENEDIAMINOBIS-ISOPROPYLPHOSPHINATE ON LEAD EXCRETION AND THE CURSE OF LEAD POISONING IN EXPERIMENTAL CONDITIONS].
    ARKHIPOVA OG; MEDVED TI; RUDOMINO MV; KABACHNIK MI
    Gig Tr Prof Zabol; 1963 Dec; 7():33-7. PubMed ID: 14147868
    [No Abstract]   [Full Text] [Related]  

  • 17. Chelation therapy in workers exposed to lead. A critical review.
    Lilis R; Fischbein A
    JAMA; 1976 Jun; 235(26):2823-4. PubMed ID: 819666
    [No Abstract]   [Full Text] [Related]  

  • 18. EFFECT OF TWO CHELATING AGENTS ON THE DISTRIBUTION AND EXCRETION OF LEAD.
    ARONSON AL; HAMMOND PB
    J Pharmacol Exp Ther; 1964 Nov; 146():241-51. PubMed ID: 14236936
    [No Abstract]   [Full Text] [Related]  

  • 19. DISTURBANCES IN THE BIOSYNTHESIS OF HEME IN LEAD INTOXICATION.
    CHISOLM JJ
    J Pediatr; 1964 Feb; 64():174-87. PubMed ID: 14119517
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment by a chelator (calcium EDTA) of a case of occupational saturnine encephalopathy].
    SAMBRON J; GASTARD J
    Therapie; 1960; 15():353-60. PubMed ID: 14441205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.